Fish Oil for Cognitive Function, Sleep Quality, and Bone Density
Launched by JINGJING JIAO · Sep 24, 2024
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1) diagnosed type 2 diabetes according to WHO diagnostic criteria or those on the use of diabetic medications; 2) between 40 and 75 years old (postmenopausal women); 3) have never used n-3 PUFA supplements before or have stopped using them for more than six months.
- Exclusion Criteria:
- • 1) type 1 diabetes; 2) coronary heart disease, stroke, cancer, hepatic or kidney disease; 3) pregnancy or lactation; 4) allergy to fish; 5) have participated in other clinical trials in the last three months.
About Jingjing Jiao
Jingjing Jiao is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, the organization specializes in designing and executing clinical trials across various therapeutic areas. Leveraging a robust network of healthcare professionals and research institutions, Jingjing Jiao emphasizes scientific rigor and ethical standards in all its studies. The sponsor aims to contribute valuable insights to the medical community and improve treatment options through collaboration and a patient-centered approach.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinhua, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported